Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
BioCryst Pharmaceuticals history
BioCryst Pharmaceuticals company history timeline
The company was founded in 1986 by Charles E. Bugg and John A. Montgomery.
In March 1994, BioCryst became a public company when it completed an initial public offering by listing its shares on the NASDAQ stock exchange.
In 2008, the company was named one of the fastest growing companies by Deloitte & Touche in its 2008 list of Technology Fast 500.
In January 2018, BioCryst signed a definitive merger agreement with Idera Pharmaceuticals, with plans for the combined company to change its name and move to Pennsylvania.
Rate how well BioCryst Pharmaceuticals lives up to its initial vision.
BioCryst Pharmaceuticals jobs
Do you work at BioCryst Pharmaceuticals?
Is BioCryst Pharmaceuticals' vision a big part of strategic planning?
BioCryst Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Chimerix | 2000 | $212,000 | 82 | - |
| Intezyne Technologies | 2004 | $2.8M | 8 | - |
| Signum Biosciences | 2004 | $1.5M | 13 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 627 |
| Sarepta Therapeutics | 1980 | $1.9B | 840 | 32 |
| TriLink BioTech | 1996 | $17.5M | 50 | 7 |
| Eurofins DiscoverX | 2000 | $8.5M | 150 | - |
| Alios BioPharma | 2006 | $15.7M | 75 | - |
BioCryst Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of BioCryst Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BioCryst Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at BioCryst Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BioCryst Pharmaceuticals. The data presented on this page does not represent the view of BioCryst Pharmaceuticals and its employees or that of Zippia.
BioCryst Pharmaceuticals may also be known as or be related to BIOCRYST PHARMACEUTICALS INC, BioCryst Pharmaceuticals, BioCryst Pharmaceuticals Inc, BioCryst Pharmaceuticals, Inc. and Biocryst Pharmaceuticals, Inc.